Europe Automated Microbiology Market, 2019-2023: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 100 Molecular, Identification, Susceptibility, Blood Culture, Urine Screening and Immunodiagnostic Tests

Europe Automated Microbiology Market Analysis, Industry Trends By Types, Regions and Forecast 2023  

The new report is a five-country strategic analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, and country; profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.

The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive five-country report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Geographic Coverage

France, Germany, Italy, Spain, UK

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major suppliers of microbiology products, by country and individual test.

- Five-year test volume and sales forecasts for over 100 microbiology assays by country.

- Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).

European Market Overview

- Review of the market dynamics, trends, structure, size, growth and major suppliers by country.

- Estimated universe of laboratories performing microbiology testing by country.
- Specimen, test volume and sales forecasts by country.

Business Opportunities and Strategic Recommendations

- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies

- Potential market entry barriers and risks.

Specimen Types

- Urine
- Sterile Fluids: Blood, Serum, CSF
- Throat Swabs, Respiratory Secretions
- Genital Secretions
- Stool
- Abscess/Wound
- Sputum
- Saliva

Applications

- Microbial Identification
- Antibiotic Susceptibility
- Urine Screening
- Blood Cultures

Review of Major Automated Systems

- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers marketed by Abbott, Alifax, BD, Beckman Coulter/Danaher, Biolog, bioMerieux, Bio-Rad, Cepheid, Curetis, GenMark, Hologic, HTG, Labsystems, Qiagen, Roche, Siemens Healthineers, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh and other suppliers.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme Disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia and others.

Technology Assessment

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.

- Global listings of companies developing or marketing microbiology products by individual test.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include:

  - Abbott
  - Affymetrix
  - Agilent Technologies
  - Applied Gene Technologies
  - Arca Biopharma
  - Beckman Coulter/Danaher
  - Becton Dickinson
  - Biokit
  - bioMerieux
  - Bio-Rad
  - Biotest
  - Cepheid
  - CellMark Forensics/LabCorp
  - Decode Genetics
  - Diadexus
  - Diamedix
  - DiaSorin
  - Eiken Chemical
  - Elitech Group
  - Enzo Biochem
  - Exact Sciences
  - Fujirebio
  - Grifols
  - Hologic/Gen-Probe
  - ID Biomedical/GSK
  - Illumina
  - Kreatech/Leica
  - Li-Cor Biosciences
  - Lonza
  - Monogram Biosciences
  - Myriad Genetics
  - Ortho-Clinical Diagnostics
  - Perkin Elmer/Caliper
  - Proteome Sciences
  - Qiagen
  - Roche
  - Scienion
  - Sequenom
  - SeraCare
  - Shimadzu
  - Siemens
  - Sierra Molecular
  - Takara Bio
  - Tecan
  - Thermo Fisher
  - Wallac/PE
  - Wako

I. Introduction
II. Worldwide Market and Technology Overview
A. Introduction
1. Major Factors Affecting Market Penetration
of Microbiology Instrumentation
2. Traditional Practices
3. Technological Challenges
4. Automation: Impact on the Microbiology
Laboratory and the Patient
B. Major Specimen Types
1. Urine
2. Sterile Fluids: Blood, Serum, and CSF
3. Throat Swabs and Respiratory Secretions
4. Genital Secretions
5. Stool
6. Abscess/Wound
7. Sputum
8. Saliva
C. Test Applications
1. Microbial Identification
2. Antibiotic Susceptibility
3. Urine Screening
a. Photometry
b. Bioluminescence
c. Colorimetric Filtration
d. Enzymatic Detection
e. Optical Detection
4. Blood Cultures
D. Major Microbiology Automated and Semiautomated Systems
1. Multiple Purpose Microbiology Systems
2. Specialized Microbiology Systems
3. Molecular Diagnostic Systems
4. Immunodiagnostic Systems
E. Emerging Diagnostic Technologies
1. Molecular Diagnostics (Amplification Methods, Sequencing,
Microarrays/Biochips)
a. DNA Sequencing
Introduction
Sequencing Methods
Autoradiography
The Human Genome Project
Sequencing Automation
Image Scanners
Fluorescent Detection
Gene Profiling
Gene Expression
Polymorphism Screening
Protein Interaction Networks
b. DNA And RNA Probe Technology
Basic Principles
Probe Preparation
The DNA Probe Test
- Sample Preparation
- Hybridization
- Separation
- Detection/Measurement
Test Formats
- Filter Hybridization
- Southern Blot
- Northern Blot
- In Situ Hybridization
- Others
Labeling Techniques
Amplification Methods
O Polymerase Chain Reaction
- Temperature Cyclers
- PCR Variations
* Immuno-PCR
* QC-PCR
* DAP-PCR
O Strand Displacement Activation
O TMA
O Ligase Chain Reaction
O Branched DNA
- Hybridization Protection Assay
O Nucleic-Acid Sequence-Based Amplification
O Self-Sustained Sequence Replicase
O Others
- Ampliprobe
- CAR
- CAS
- CPT
- Dendritic Polymer Technology
- ISO-CR
- LAT
- Probe
- RAMP
- Repair Chain Reaction
- Rolling Circles
- Sequence Independent Gene Amplification
- Sequence Initiation Reaction
- SISPA
- Solid Phase Amplification
c. Detection Technologies
Radioactive Methods
- Overview
- Major Isotopes
O P-32
O S-35
O H-3
O I-125
Non-Isotopic Methods
- Enzymatic Labels
- Chemical Labeling
O Indirect Chemical Labeling
O Direct Chemical Labeling
- Fluorescence
- Chemiluminescence
- Electrical Conductivity
d. Biochips: Genosensors, Microarrays,
and Labs-on-the-Chip
- Liquid Transportation and Mixing
- Separation
- Reaction
- Detection
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
III. France
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
IV. Germany
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
V. Italy
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
VI. Spain
A. Business Environment
B. Market Structure
C. Market Size, Growth And Major Supplier Sales and Market Shares
VII. U.K.
A. Business Environment
B. Market Structure
C. Market Size, Growth and Major Supplier Sales and Market Shares
VIII. Major Product Development Opportunities
IX. Design Criteria for Decentralized Testing Products
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Pharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- Cepheid
- CellMark Forenciscs/LabCorp
- Decode
- Diadexus
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Illumina
- ID Biomedical/GSK
- Kreatech/Leica
- Li-Cor Biosciences
- Lonza
- Monogram Biosciences
- Myriad Genetics
- Ortho-Clinical Diagnostics
- Perkin Elmer/Caliper
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Sierra Molecular
- Shimadzu
- Takara Bio
- Tecan
- Thermo Fisher
- Wallac/PE
- Wako

List Of Tables

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests

Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests

Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
France
Laboratories Performing Microbiology Tests by Market Segment
France
Hospital Laboratories Performing Microbiology Tests by Bed Size
France
Commercial/Private Laboratories Performing Microbiology Tests
by Annual Test Volume
France
All Market Segments Microbiology Specimen Volume
France
Hospital Laboratories Microbiology Specimen Volume
France
Commercial/Private Laboratories Microbiology Specimen Volume
France
Microbiology Test Volume by Market Segment
France
Microbiology Test Volume by Application

France
Blood Culture Test Volume by Market Segment
France
Microbial Identification Test Volume by Market Segment
France
Urine Screening Test Volume by Market Segment
France
Antibiotic Susceptibility Test Volume by Market Segment
France
Microbiology Consumables Market by Application
France
Microbiology Consumables Market by Market Segment
France
Microbial Identification Consumables Sales by Market Segment
France
Blood Culture Consumables Sales by Market Segment
France
Antibiotic Susceptibility Consumables Sales by Market Segment
France
Urine Screening Consumables Sales by Market Segment
France
All Market Segments Infectious Disease Test Volume Forecast by Assay
France
All Market Segments Infectious Disease Diagnostics Market Forecast by Test
France
Infectious Disease Blood Screening NAT Volume Forecast by Assay
France
Infectious Disease Blood Screening NAT Reagent Market Forecast by Assay

Fill The Form For Sample Request

There is no Reviews available